MicroPort CardioFlow Company
Shanghai MicroPort CardioFlow Medtech provides advanced minimally invasive therapies for structural heart diseases.
Employee Number:
501-1000
Headquarters:
Shanghai,Shanghai,China,Asia
Founded Date:
2015-01-01
Industry:
Advanced BioTech R&D
Sub-Industry:
PharmTech
Investors:
Hillhouse Investment, Apricot Capital, 3H Health Investment, CPE, China Reform Fund Management
Ipo Status:
public
City:
Shanghai
Region:
Shanghai
Country:
China